Kymera Therapeutics
Price & Volume
Stats
See moreOpen | $90.13 |
Previous Close | $89.86 |
Day Range | $88.47-$90.84 |
52W Range | $24.72-$103 |
Market Cap | $7.2B |
Shares Short | 10M |
Financials
See moreRevenue (12 Mos) | $39.2M |
Revenue Growth (YoY) | -61.2% |
Gross Profit (12 Mos) | -$277.3M |
Diluted EPS | -$3.69 |
News
See moreYahoo Finance • 2 days ago
Kymera Therapeutics Gets FDA Fast Track Status For KT-621 In Asthma
Yahoo Finance • 14 days ago
5 Biotechs That Big Pharma Could Snap Up as Oncology M&A Heats Up
Yahoo Finance • 18 days ago
Kymera Therapeutics Presents KT-621 BroADen Data in Late-Breaking Research Session at the American Academy of Dermatology (AAD) Annual Meeting
Yahoo Finance • last month
Investment Manager Loads Up on CELC Stock, Adds 135,000 Shares, According to Latest SEC Filing
About
CEO | Dr. Nello Mainolfi M.D., Ph.D. |
Address | 500 North Beacon Street, Watertown, MA, United States, 02472 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 238 |
